MetLife Investment Management’s MiMedx Group MDXG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $434K | Buy |
70,995
+2,233
| +3% | +$13.6K | ﹤0.01% | 1743 |
|
2025
Q1 | $523K | Sell |
68,762
-4,544
| -6% | -$34.5K | ﹤0.01% | 1706 |
|
2024
Q4 | $705K | Buy |
73,306
+6,673
| +10% | +$64.2K | ﹤0.01% | 1603 |
|
2024
Q3 | $394K | Hold |
66,633
| – | – | ﹤0.01% | 1910 |
|
2024
Q2 | $462K | Buy |
66,633
+11,901
| +22% | +$82.5K | ﹤0.01% | 1759 |
|
2024
Q1 | $421K | Sell |
54,732
-5,261
| -9% | -$40.5K | ﹤0.01% | 1772 |
|
2023
Q4 | $526K | Hold |
59,993
| – | – | ﹤0.01% | 1659 |
|
2023
Q3 | $437K | Hold |
59,993
| – | – | ﹤0.01% | 1712 |
|
2023
Q2 | $397K | Hold |
59,993
| – | – | ﹤0.01% | 1855 |
|
2023
Q1 | $205K | Buy |
59,993
+11,153
| +23% | +$38K | ﹤0.01% | 2209 |
|
2022
Q4 | $136K | Sell |
48,840
-13,023
| -21% | -$36.2K | ﹤0.01% | 2464 |
|
2022
Q3 | $178K | Buy |
61,863
+7,298
| +13% | +$20.9K | ﹤0.01% | 2372 |
|
2022
Q2 | $189K | Sell |
54,565
-8,246
| -13% | -$28.6K | ﹤0.01% | 2360 |
|
2022
Q1 | $296K | Buy |
62,811
+22,593
| +56% | +$106K | ﹤0.01% | 2105 |
|
2021
Q4 | $243K | Buy |
40,218
+13,960
| +53% | +$84.3K | ﹤0.01% | 1940 |
|
2021
Q3 | $159K | Sell |
26,258
-14,876
| -36% | -$90.1K | ﹤0.01% | 2225 |
|
2021
Q2 | $515K | Buy |
+41,134
| New | +$515K | ﹤0.01% | 1550 |
|
2018
Q4 | – | Sell |
-48,233
| Closed | -$298K | – | 2585 |
|
2018
Q3 | $298K | Hold |
48,233
| – | – | ﹤0.01% | 1860 |
|
2018
Q2 | $308K | Hold |
48,233
| – | – | ﹤0.01% | 1706 |
|
2018
Q1 | $336K | Hold |
48,233
| – | – | ﹤0.01% | 1622 |
|
2017
Q4 | $608K | Buy |
+48,233
| New | +$608K | 0.01% | 1291 |
|